MobiHealth News May 22, 2025
The funds will be used to support building a GMP system for long-acting injectables and grow the company’s robotic lab.
Persist AI, an AI-driven robotics platform for the pharmaceutical industry, announced an overscribed $12 million Series A funding round.
Spero Ventures led the round, with participation from MBX Capital, Shimadzu Future Innovation Fund managed by Global Brain Corporation, Eli Lilly & Company, SignalFire, Ford Street Capital, Purdue Ventures, Good AI Capital, Cartography Capital, Asymmetry Ventures and existing investors 2048 Ventures, Innospark and YCombinator.
The company also announced the launch of its Cloud Lab platform, which enables pharmaceutical companies to develop formulations using Persist AI’s state-of-the-art robotic laboratory facilities via a website.
The aim is to expedite drug development timelines using...
Today's Sponsors
Today's Sponsor